LBF20107PG01 - Revision history

https://lipidbank.jp/mediawiki/index.php?action=history&feed=atom&title=LBF20107PG01 LBF20107PG01 - Revision history 2026-06-14T05:22:36Z Revision history for this page on the wiki MediaWiki 1.43.0 https://lipidbank.jp/mediawiki/index.php?title=LBF20107PG01&diff=51507&oldid=prev Editor at 07:59, 21 October 2010 2010-10-21T07:59:58Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 16:59, 21 October 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1400</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1400</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010134</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010134</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=7- [3R- Hydroxy- 2R- (3S -hydroxy-1<del style="font-weight: bold; text-decoration: none;">-trans </del>-octenyl) -5-oxocyclopentan-1R-yl] -heptanoic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=7- [3R- Hydroxy- 2R- (3S-hydroxy<ins style="font-weight: bold; text-decoration: none;">-trans</ins>-1-octenyl) -5-oxocyclopentan-1R-yl] -heptanoic acid</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Prostaglandin E_1&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&7- [3R- Hydroxy- 2R- (3S -hydroxy-1(E) -octenyl) -5-oxocyclopentan-1R-yl] -heptanoic acid&&</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Prostaglandin E_1&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&7- [3R- Hydroxy- 2R- (3S -hydroxy-1(E) -octenyl) -5-oxocyclopentan-1R-yl] -heptanoic acid&&</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C[[Reference:Bergstrom_S:Sjoevall_J:,Acta_Chem._Scand.,1960,14,1701|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:Sjoevall_J:,Acta_Chem._Scand.,1960,14,1701}}]] </div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C[[Reference:Bergstrom_S:Sjoevall_J:,Acta_Chem._Scand.,1960,14,1701|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:Sjoevall_J:,Acta_Chem._Scand.,1960,14,1701}}]] </div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20107PG01&diff=51506&oldid=prev Editor at 04:41, 9 June 2010 2010-06-09T04:41:12Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 13:41, 9 June 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l8">Line 8:</td> <td colspan="2" class="diff-lineno">Line 8:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=7- [3R- Hydroxy- 2R- (3S -hydroxy-1-trans -octenyl) -5-oxocyclopentan-1R-yl] -heptanoic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=7- [3R- Hydroxy- 2R- (3S -hydroxy-1-trans -octenyl) -5-oxocyclopentan-1R-yl] -heptanoic acid</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Prostaglandin E_1&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&7- [3R- Hydroxy- 2R- (3S -hydroxy-1(E) -octenyl) -5-oxocyclopentan-1R-yl] -heptanoic acid&&</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Prostaglandin E_1&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&7- [3R- Hydroxy- 2R- (3S -hydroxy-1(E) -octenyl) -5-oxocyclopentan-1R-yl] -heptanoic acid&&</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C <del style="font-weight: bold; text-decoration: none;"></del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C<ins style="font-weight: bold; text-decoration: none;">[[Reference:Bergstrom_S:Sjoevall_J:,Acta_Chem._Scand.,1960,14,1701|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:Sjoevall_J:,Acta_Chem._Scand.,1960,14,1701}}]] </ins></div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[ alpha ]_{578}=-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[ alpha ]_{578}=-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Solubility=DIETHYL ETHER, ETHYL ACETATE <del style="font-weight: bold; text-decoration: none;"></del>, METHANOL [[Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233|{{RelationTable/GetFirstAuthor|Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233}}]], TETRAHYDROFURAN [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Solubility=DIETHYL ETHER, ETHYL ACETATE<ins style="font-weight: bold; text-decoration: none;">[[Reference:Bergstrom_S:Sjoevall_J:,Acta_Chem._Scand.,1960,14,1701|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:Sjoevall_J:,Acta_Chem._Scand.,1960,14,1701}}]] </ins>, METHANOL [[Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233|{{RelationTable/GetFirstAuthor|Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233}}]], TETRAHYDROFURAN [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Mass Spectra=METHYL ESTER ; m/e 350, 332, 319, 301, 279 [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Mass Spectra=METHYL ESTER ; m/e 350, 332, 319, 301, 279 [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|IR Spectra=METHYL ESTER ; nu 1726, 1717sh, 1699, 980 cm^{-1} [[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|IR Spectra=METHYL ESTER ; nu 1726, 1717sh, 1699, 980 cm^{-1} [[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20107PG01&diff=51505&oldid=prev Editor at 02:55, 9 June 2010 2010-06-09T02:55:29Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 11:55, 9 June 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l18">Line 18:</td> <td colspan="2" class="diff-lineno">Line 18:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=Prostagalndin E1 is produced from H1 at almost the same rate of E2 synthesis from H2 by an enzyme of bovine seminal vesicle [[Reference:Ogino_N:Miyamoto_T:Yamamoto_S:Hayaishi_O:,J. Biol. Chem.,1977,252,890|{{RelationTable/GetFirstAuthor|Reference:Ogino_N:Miyamoto_T:Yamamoto_S:Hayaishi_O:,J. Biol. Chem.,1977,252,890}}]].</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=Prostagalndin E1 is produced from H1 at almost the same rate of E2 synthesis from H2 by an enzyme of bovine seminal vesicle [[Reference:Ogino_N:Miyamoto_T:Yamamoto_S:Hayaishi_O:,J. Biol. Chem.,1977,252,890|{{RelationTable/GetFirstAuthor|Reference:Ogino_N:Miyamoto_T:Yamamoto_S:Hayaishi_O:,J. Biol. Chem.,1977,252,890}}]].</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=PGE1</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=PGE1</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=Prostaglandin E1 is generally considered as active as E2, and the biological activities of both compounds are compared in references [[Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1}}]]<del style="font-weight: bold; text-decoration: none;"></del>. However, platelet aggregation is inhibited by prostaglandin E1 whereas prostaglandin E2 is much less active [[Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1}}]].</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=Prostaglandin E1 is generally considered as active as E2, and the biological activities of both compounds are compared in references [[Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1}}]]<ins style="font-weight: bold; text-decoration: none;">[[Reference: Horton_EW:Main_IHM:,Mem._Soc._Endocr.,1966,14,29|{{RelationTable/GetFirstAuthor|Reference: Horton_EW:Main_IHM:,Mem._Soc._Endocr.,1966,14,29}}]]</ins>. However, platelet aggregation is inhibited by prostaglandin E1 whereas prostaglandin E2 is much less active [[Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1}}]].</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20107PG01&diff=51504&oldid=prev Editor at 11:07, 1 June 2010 2010-06-01T11:07:57Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 20:07, 1 June 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1400</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1400</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010134</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010134</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=7- [ <del style="font-weight: bold; text-decoration: none;">3 (R) </del>-Hydroxy-<del style="font-weight: bold; text-decoration: none;">2 (R) </del>- (<del style="font-weight: bold; text-decoration: none;">3 (S) </del>-hydroxy-1 <del style="font-weight: bold; text-decoration: none;">(E) </del>-octenyl) -5-oxocyclopentan-<del style="font-weight: bold; text-decoration: none;">1 (R) </del>-yl ] -heptanoic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=7- [<ins style="font-weight: bold; text-decoration: none;">3R</ins>- Hydroxy- <ins style="font-weight: bold; text-decoration: none;">2R</ins>- (<ins style="font-weight: bold; text-decoration: none;">3S </ins>-hydroxy-1<ins style="font-weight: bold; text-decoration: none;">-trans </ins>-octenyl) -5-oxocyclopentan-<ins style="font-weight: bold; text-decoration: none;">1R</ins>-yl] -heptanoic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Prostaglandin E_1&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Prostaglandin E_1&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic <ins style="font-weight: bold; text-decoration: none;">acid&&7- [3R- Hydroxy- 2R- (3S -hydroxy-1(E) -octenyl) -5-oxocyclopentan-1R-yl] -heptanoic </ins>acid&&</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C </div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C </div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[ alpha ]_{578}=-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[ alpha ]_{578}=-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20107PG01&diff=51503&oldid=prev Editor at 02:41, 20 April 2010 2010-04-20T02:41:33Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 11:41, 20 April 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1400</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1400</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010134</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010134</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic <del style="font-weight: bold; text-decoration: none;">acid / (8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic </del>acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Prostaglandin E_1<del style="font-weight: bold; text-decoration: none;">&&7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid</del>&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Prostaglandin E_1&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C </div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C </div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[ alpha ]_{578}=-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[ alpha ]_{578}=-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20107PG01&diff=51502&oldid=prev Editor at 02:39, 20 April 2010 2010-04-20T02:39:46Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 11:39, 20 April 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7">Line 7:</td> <td colspan="2" class="diff-lineno">Line 7:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010134</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010134</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid / (8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid / (8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&<del style="font-weight: bold; text-decoration: none;">PROSTAGLANDIN </del>E_1&&7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&<ins style="font-weight: bold; text-decoration: none;">Prostaglandin </ins>E_1&&7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C </div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C </div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[ alpha ]_{578}=-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[ alpha ]_{578}=-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20107PG01&diff=51501&oldid=prev Editor at 21:00, 14 April 2010 2010-04-14T21:00:00Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 06:00, 15 April 2010</td> </tr><tr><td colspan="4" class="diff-notice" lang="en"><div class="mw-diff-empty">(No difference)</div> </td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20107PG01&diff=51500&oldid=prev Editor at 10:00, 25 February 2010 2010-02-25T10:00:10Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 19:00, 25 February 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l9">Line 9:</td> <td colspan="2" class="diff-lineno">Line 9:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&PROSTAGLANDIN E_1&&7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&PROSTAGLANDIN E_1&&7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C </div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C </div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[ alpha ]<del style="font-weight: bold; text-decoration: none;">_5 _7 _8 </del>=-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[ alpha ]<ins style="font-weight: bold; text-decoration: none;">_{578}</ins>=-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Solubility=DIETHYL ETHER, ETHYL ACETATE , METHANOL [[Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233|{{RelationTable/GetFirstAuthor|Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233}}]], TETRAHYDROFURAN [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Solubility=DIETHYL ETHER, ETHYL ACETATE , METHANOL [[Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233|{{RelationTable/GetFirstAuthor|Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233}}]], TETRAHYDROFURAN [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Mass Spectra=METHYL ESTER ; m/e 350, 332, 319, 301, 279 [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Mass Spectra=METHYL ESTER ; m/e 350, 332, 319, 301, 279 [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|IR Spectra=METHYL ESTER ; nu 1726, 1717sh, 1699, 980 cm^- <del style="font-weight: bold; text-decoration: none;">^</del>1 <del style="font-weight: bold; text-decoration: none;"> </del>[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|IR Spectra=METHYL ESTER ; nu 1726, 1717sh, 1699, 980 cm^<ins style="font-weight: bold; text-decoration: none;">{</ins>-1<ins style="font-weight: bold; text-decoration: none;">} </ins>[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|NMR Spectra=^1 H-NMR(CDCl_3 +DMSO-d_6 ,TMS) : delta 5.70-5.51(m, 2H), 4.14-3.86(m, 2H), 2.72(d,d, 1H)[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]. ^<del style="font-weight: bold; text-decoration: none;">1 ^3 </del>C-NMR(CHCl_3 -CH_3 OH, TMS) : delta 215.2(C-9), 176.7(C-1), 136.6(C-14), 131.9(C-13), 72.9(C-15), 71.6(C-11), 54.6(C-8), 54.2(C-12), 45.9(C-10), 36.9(C-16), 33.8(C-2), 31.5(C-18), 29.0(C-4), 28.6(C-5), 27.4(C-7), 26.3(C-6), 25.0(C-17), 24.5(C-3), 22.5(C-19), 13.8(C-20) [[Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515|{{RelationTable/GetFirstAuthor|Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515}}]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|NMR Spectra=^1 H-NMR(CDCl_3 +DMSO-d_6 ,TMS) : delta 5.70-5.51(m, 2H), 4.14-3.86(m, 2H), 2.72(d,d, 1H)[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]. ^<ins style="font-weight: bold; text-decoration: none;">{13}</ins>C-NMR(CHCl_3 -CH_3 OH, TMS) : delta 215.2(C-9), 176.7(C-1), 136.6(C-14), 131.9(C-13), 72.9(C-15), 71.6(C-11), 54.6(C-8), 54.2(C-12), 45.9(C-10), 36.9(C-16), 33.8(C-2), 31.5(C-18), 29.0(C-4), 28.6(C-5), 27.4(C-7), 26.3(C-6), 25.0(C-17), 24.5(C-3), 22.5(C-19), 13.8(C-20) [[Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515|{{RelationTable/GetFirstAuthor|Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=Prostaglandin E1 is contained in human seminal plasma in an amount of 25 microgram/ml [[Reference:Bergstrom_S:,Science,1967,157,382|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:,Science,1967,157,382}}]], and has been found in ovine seminal plasma and seminal vesicle, human menstrual and amniotic flluid, human uterine endometrium, umbilical cord, placental vessels and decidua, frog spinal cord, rat adrenal, human and bovine thymus, frog intestine, rat fat tissue, and human phrenic nerve [[Reference:Horton_EW:,Physiol. Rev.,1969,49,122|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Physiol. Rev.,1969,49,122}}]][[Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111|{{RelationTable/GetFirstAuthor|Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111}}]][[Reference:Horton_EW:,Experientia,1965,21,113|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Experientia,1965,21,113}}]][[Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749}}]][[Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340}}]][[Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165|{{RelationTable/GetFirstAuthor|Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165}}]].</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=Prostaglandin E1 is contained in human seminal plasma in an amount of 25 microgram/ml [[Reference:Bergstrom_S:,Science,1967,157,382|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:,Science,1967,157,382}}]], and has been found in ovine seminal plasma and seminal vesicle, human menstrual and amniotic flluid, human uterine endometrium, umbilical cord, placental vessels and decidua, frog spinal cord, rat adrenal, human and bovine thymus, frog intestine, rat fat tissue, and human phrenic nerve [[Reference:Horton_EW:,Physiol. Rev.,1969,49,122|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Physiol. Rev.,1969,49,122}}]][[Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111|{{RelationTable/GetFirstAuthor|Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111}}]][[Reference:Horton_EW:,Experientia,1965,21,113|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Experientia,1965,21,113}}]][[Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749}}]][[Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340}}]][[Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165|{{RelationTable/GetFirstAuthor|Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165}}]].</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=[[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]] {{Image200|LBF20107PG01FT0001.gif}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=[[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]] {{Image200|LBF20107PG01FT0001.gif}}</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20107PG01&diff=51499&oldid=prev Editor at 14:00, 19 February 2010 2010-02-19T14:00:10Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 23:00, 19 February 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l9">Line 9:</td> <td colspan="2" class="diff-lineno">Line 9:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&PROSTAGLANDIN E_1&&7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&PROSTAGLANDIN E_1&&7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C </div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C </div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[alpha]_5 _7 _8 =-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[ alpha ]_5 _7 _8 =-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Solubility=DIETHYL ETHER, ETHYL ACETATE , METHANOL [[Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233|{{RelationTable/GetFirstAuthor|Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233}}]], TETRAHYDROFURAN [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Solubility=DIETHYL ETHER, ETHYL ACETATE , METHANOL [[Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233|{{RelationTable/GetFirstAuthor|Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233}}]], TETRAHYDROFURAN [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Mass Spectra=METHYL ESTER ; m/e 350, 332, 319, 301, 279 [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Mass Spectra=METHYL ESTER ; m/e 350, 332, 319, 301, 279 [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|IR Spectra=METHYL ESTER ; nu 1726, 1717sh, 1699, 980 cm^- ^1 [[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|IR Spectra=METHYL ESTER ; <ins style="font-weight: bold; text-decoration: none;"> </ins>nu <ins style="font-weight: bold; text-decoration: none;"> </ins>1726, 1717sh, 1699, 980 cm^- ^1 [[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|NMR Spectra=^1 H-NMR(CDCl_3 +DMSO-d_6 ,TMS) : delta 5.70-5.51(m, 2H), 4.14-3.86(m, 2H), 2.72(d,d, 1H)[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]. ^1 ^3 C-NMR(CHCl_3 -CH_3 OH, TMS) : delta 215.2(C-9), 176.7(C-1), 136.6(C-14), 131.9(C-13), 72.9(C-15), 71.6(C-11), 54.6(C-8), 54.2(C-12), 45.9(C-10), 36.9(C-16), 33.8(C-2), 31.5(C-18), 29.0(C-4), 28.6(C-5), 27.4(C-7), 26.3(C-6), 25.0(C-17), 24.5(C-3), 22.5(C-19), 13.8(C-20) [[Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515|{{RelationTable/GetFirstAuthor|Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515}}]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|NMR Spectra=^1 H-NMR(CDCl_3 +DMSO-d_6 ,TMS) : <ins style="font-weight: bold; text-decoration: none;"> </ins>delta <ins style="font-weight: bold; text-decoration: none;"> </ins>5.70-5.51(m, 2H), 4.14-3.86(m, 2H), 2.72(d,d, 1H)[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]. ^1 ^3 C-NMR(CHCl_3 -CH_3 OH, TMS) : <ins style="font-weight: bold; text-decoration: none;"> </ins>delta <ins style="font-weight: bold; text-decoration: none;"> </ins>215.2(C-9), 176.7(C-1), 136.6(C-14), 131.9(C-13), 72.9(C-15), 71.6(C-11), 54.6(C-8), 54.2(C-12), 45.9(C-10), 36.9(C-16), 33.8(C-2), 31.5(C-18), 29.0(C-4), 28.6(C-5), 27.4(C-7), 26.3(C-6), 25.0(C-17), 24.5(C-3), 22.5(C-19), 13.8(C-20) [[Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515|{{RelationTable/GetFirstAuthor|Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=Prostaglandin E1 is contained in human seminal plasma in an amount of 25 microgram/ml [[Reference:Bergstrom_S:,Science,1967,157,382|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:,Science,1967,157,382}}]], and has been found in ovine seminal plasma and seminal vesicle, human menstrual and amniotic flluid, human uterine endometrium, umbilical cord, placental vessels and decidua, frog spinal cord, rat adrenal, human and bovine thymus, frog intestine, rat fat tissue, and human phrenic nerve [[Reference:Horton_EW:,Physiol. Rev.,1969,49,122|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Physiol. Rev.,1969,49,122}}]][[Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111|{{RelationTable/GetFirstAuthor|Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111}}]][[Reference:Horton_EW:,Experientia,1965,21,113|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Experientia,1965,21,113}}]][[Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749}}]][[Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340}}]][[Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165|{{RelationTable/GetFirstAuthor|Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165}}]].</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=Prostaglandin E1 is contained in human seminal plasma in an amount of 25 microgram/ml [[Reference:Bergstrom_S:,Science,1967,157,382|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:,Science,1967,157,382}}]], and has been found in ovine seminal plasma and seminal vesicle, human menstrual and amniotic flluid, human uterine endometrium, umbilical cord, placental vessels and decidua, frog spinal cord, rat adrenal, human and bovine thymus, frog intestine, rat fat tissue, and human phrenic nerve [[Reference:Horton_EW:,Physiol. Rev.,1969,49,122|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Physiol. Rev.,1969,49,122}}]][[Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111|{{RelationTable/GetFirstAuthor|Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111}}]][[Reference:Horton_EW:,Experientia,1965,21,113|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Experientia,1965,21,113}}]][[Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749}}]][[Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340}}]][[Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165|{{RelationTable/GetFirstAuthor|Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165}}]].</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=[[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]] {{Image200|LBF20107PG01FT0001.gif}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=[[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]] {{Image200|LBF20107PG01FT0001.gif}}</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20107PG01&diff=51498&oldid=prev Editor at 14:00, 19 February 2010 2010-02-19T14:00:00Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 23:00, 19 February 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l9">Line 9:</td> <td colspan="2" class="diff-lineno">Line 9:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&PROSTAGLANDIN E_1&&7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&PROSTAGLANDIN E_1&&7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid&&(8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid&&</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C </div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=115-117°C </div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[<del style="font-weight: bold; text-decoration: none;"><FONT FACE="Symbol">a</FONT></del>]<del style="font-weight: bold; text-decoration: none;"><SUB><FONT SIZE=-1>5</FONT></SUB><SUB><FONT SIZE=-1>7</FONT></SUB><SUB><FONT SIZE=-1>8</FONT></SUB></del>=-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Optical=[<ins style="font-weight: bold; text-decoration: none;">alpha</ins>]<ins style="font-weight: bold; text-decoration: none;">_5 _7 _8 </ins>=-61.6°(C=0.56, TETRAHYDROFURAN) [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Solubility=DIETHYL ETHER, ETHYL ACETATE , METHANOL [[Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233|{{RelationTable/GetFirstAuthor|Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233}}]], TETRAHYDROFURAN [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Solubility=DIETHYL ETHER, ETHYL ACETATE , METHANOL [[Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233|{{RelationTable/GetFirstAuthor|Reference:Struijk_MCB:Beerthuis_RK:Pabon_HJJ:Van_Dorp_DA:,Recueil Travaux Quimiq Pays Bas,1966,85,1233}}]], TETRAHYDROFURAN [[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Mass Spectra=METHYL ESTER ; m/e 350, 332, 319, 301, 279 [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Mass Spectra=METHYL ESTER ; m/e 350, 332, 319, 301, 279 [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|IR Spectra=METHYL ESTER ; <del style="font-weight: bold; text-decoration: none;"><FONT FACE="Symbol">n</FONT> </del>1726, 1717sh, 1699, 980 cm<del style="font-weight: bold; text-decoration: none;"><SUP><FONT SIZE=</del>-1<del style="font-weight: bold; text-decoration: none;">>-</FONT></SUP><SUP><FONT SIZE=-1>1</FONT></SUP> </del>[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|IR Spectra=METHYL ESTER ; <ins style="font-weight: bold; text-decoration: none;">nu </ins>1726, 1717sh, 1699, 980 cm<ins style="font-weight: bold; text-decoration: none;">^</ins>- <ins style="font-weight: bold; text-decoration: none;">^</ins>1 <ins style="font-weight: bold; text-decoration: none;"> </ins>[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|NMR Spectra=<del style="font-weight: bold; text-decoration: none;"><SUP><FONT SIZE=-</del>1<del style="font-weight: bold; text-decoration: none;">>1</FONT></SUP></del>H-NMR(<del style="font-weight: bold; text-decoration: none;">CDCl<SUB><FONT SIZE=-1>3</FONT></SUB></del>+DMSO-<del style="font-weight: bold; text-decoration: none;">d<SUB><FONT SIZE=-1>6</FONT></SUB></del>,TMS) : <del style="font-weight: bold; text-decoration: none;"><FONT FACE="Symbol">d</FONT> </del>5.70-5.51(m, 2H), 4.14-3.86(m, 2H), 2.72(d,d, 1H)[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]. <del style="font-weight: bold; text-decoration: none;"><SUP><FONT SIZE=-1>1</FONT></SUP><SUP><FONT SIZE=-</del>1<del style="font-weight: bold; text-decoration: none;">></del>3<del style="font-weight: bold; text-decoration: none;"></FONT></SUP></del>C-NMR(<del style="font-weight: bold; text-decoration: none;">CHCl<SUB><FONT SIZE=-1>3</FONT></SUB>-CH<SUB><FONT SIZE=</del>-<del style="font-weight: bold; text-decoration: none;">1>3</FONT></SUB></del>OH, TMS) : <del style="font-weight: bold; text-decoration: none;"><FONT FACE="Symbol">d</FONT> </del>215.2(C-9), 176.7(C-1), 136.6(C-14), 131.9(C-13), 72.9(C-15), 71.6(C-11), 54.6(C-8), 54.2(C-12), 45.9(C-10), 36.9(C-16), 33.8(C-2), 31.5(C-18), 29.0(C-4), 28.6(C-5), 27.4(C-7), 26.3(C-6), 25.0(C-17), 24.5(C-3), 22.5(C-19), 13.8(C-20) [[Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515|{{RelationTable/GetFirstAuthor|Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515}}]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|NMR Spectra=<ins style="font-weight: bold; text-decoration: none;">^</ins>1 H-NMR(<ins style="font-weight: bold; text-decoration: none;">CDCl_3 </ins>+DMSO-<ins style="font-weight: bold; text-decoration: none;">d_6 </ins>,TMS) : <ins style="font-weight: bold; text-decoration: none;">delta </ins>5.70-5.51(m, 2H), 4.14-3.86(m, 2H), 2.72(d,d, 1H)[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]. <ins style="font-weight: bold; text-decoration: none;">^</ins>1 <ins style="font-weight: bold; text-decoration: none;">^</ins>3 C-NMR(<ins style="font-weight: bold; text-decoration: none;">CHCl_3 </ins>-<ins style="font-weight: bold; text-decoration: none;">CH_3 </ins>OH, TMS) : <ins style="font-weight: bold; text-decoration: none;">delta </ins>215.2(C-9), 176.7(C-1), 136.6(C-14), 131.9(C-13), 72.9(C-15), 71.6(C-11), 54.6(C-8), 54.2(C-12), 45.9(C-10), 36.9(C-16), 33.8(C-2), 31.5(C-18), 29.0(C-4), 28.6(C-5), 27.4(C-7), 26.3(C-6), 25.0(C-17), 24.5(C-3), 22.5(C-19), 13.8(C-20) [[Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515|{{RelationTable/GetFirstAuthor|Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=Prostaglandin E1 is contained in human seminal plasma in an amount of 25 microgram/ml [[Reference:Bergstrom_S:,Science,1967,157,382|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:,Science,1967,157,382}}]], and has been found in ovine seminal plasma and seminal vesicle, human menstrual and amniotic flluid, human uterine endometrium, umbilical cord, placental vessels and decidua, frog spinal cord, rat adrenal, human and bovine thymus, frog intestine, rat fat tissue, and human phrenic nerve [[Reference:Horton_EW:,Physiol. Rev.,1969,49,122|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Physiol. Rev.,1969,49,122}}]][[Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111|{{RelationTable/GetFirstAuthor|Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111}}]][[Reference:Horton_EW:,Experientia,1965,21,113|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Experientia,1965,21,113}}]][[Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749}}]][[Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340}}]][[Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165|{{RelationTable/GetFirstAuthor|Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165}}]].</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=Prostaglandin E1 is contained in human seminal plasma in an amount of 25 microgram/ml [[Reference:Bergstrom_S:,Science,1967,157,382|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:,Science,1967,157,382}}]], and has been found in ovine seminal plasma and seminal vesicle, human menstrual and amniotic flluid, human uterine endometrium, umbilical cord, placental vessels and decidua, frog spinal cord, rat adrenal, human and bovine thymus, frog intestine, rat fat tissue, and human phrenic nerve [[Reference:Horton_EW:,Physiol. Rev.,1969,49,122|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Physiol. Rev.,1969,49,122}}]][[Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111|{{RelationTable/GetFirstAuthor|Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111}}]][[Reference:Horton_EW:,Experientia,1965,21,113|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Experientia,1965,21,113}}]][[Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749}}]][[Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340}}]][[Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165|{{RelationTable/GetFirstAuthor|Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165}}]].</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=[[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]] {{Image200|LBF20107PG01FT0001.gif}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=[[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]] {{Image200|LBF20107PG01FT0001.gif}}</div></td></tr>  </table>

Editor